{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:33:35Z","timestamp":1782977615864,"version":"3.54.5"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bbr.2023.114757","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:36:59Z","timestamp":1699659419000},"page":"114757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Modeling Huntington\u2019s disease: An insight on in-vitro and in-vivo models"],"prefix":"10.1016","volume":"459","author":[{"given":"Nitasha","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshay","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-4930","authenticated-orcid":false,"given":"Arti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbr.2023.114757_bib2","unstructured":"Bruyn, G., Handbook of clinical neurology (Vol. 4). Amsterdam: North, 1968."},{"issue":"4\u20135","key":"10.1016\/j.bbr.2023.114757_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.1998.7006","article-title":"Recent advances on the pathogenesis of Huntington's disease","volume":"157","author":"Peters\u00e9n","year":"1999","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.bbr.2023.114757_bib5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/brainsci12101389","article-title":"Pathogenesis of Huntington\u2019s disease: an emphasis on molecular pathways and prevention by natural remedies","volume":"12","author":"Irfan","year":"2022","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib6","first-page":"213","article-title":"Some observations on the spectrum of dementia","volume":"52","author":"Jha","year":"2004","journal-title":"Neurol. India"},{"key":"10.1016\/j.bbr.2023.114757_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-444-63233-3.00017-8","article-title":"Huntington disease","volume":"147","author":"Ghosh","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mds.24024","article-title":"Age, CAG repeat length, and clinical progression in Huntington's disease","volume":"27","author":"Rosenblatt","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2023.114757_bib9","first-page":"113","article-title":"Huntington's disease: genetic and molecular studies","volume":"45","author":"Harper","year":"2002","journal-title":"Oxf. Monogr. Med. Genet."},{"issue":"7","key":"10.1016\/j.bbr.2023.114757_bib10","doi-asserted-by":"crossref","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F","article-title":"Pathophysiology of chorea and bradykinesia in Huntington's disease","volume":"14","author":"Berardelli","year":"1999","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.bbr.2023.114757_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"17","key":"10.1016\/j.bbr.2023.114757_bib14","doi-asserted-by":"crossref","first-page":"13142","DOI":"10.1074\/jbc.M110.114561","article-title":"A role for huntington disease protein in dendritic RNA granules","volume":"285","author":"Savas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2023.114757_bib15","doi-asserted-by":"crossref","unstructured":"STAHL, W.L. and P.D. SWANSON, Biochemical abnormalities in Huntington's chorea brains. Neurology, 1974. 24(9): p. 813\u2013813.","DOI":"10.1212\/WNL.24.9.813"},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcb.20743","article-title":"Nuclear control of respiratory gene expression in mammalian cells","volume":"97","author":"Scarpulla","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s42826-022-00128-1","article-title":"Role of animal models in biomedical research: a review","volume":"38","author":"Mukherjee","year":"2022","journal-title":"Lab. Anim. Res."},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib20","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.63","article-title":"Animal models are essential to biological research: issues and perspectives","volume":"1","author":"Barr\u00e9-Sinoussi","year":"2015","journal-title":"Future Sci. OA"},{"issue":"3\u20134","key":"10.1016\/j.bbr.2023.114757_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/dmm.002451","article-title":"Mouse models of Huntington disease: variations on a theme","volume":"2","author":"Ehrnhoefer","year":"2009","journal-title":"Dis. Models Mech."},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"Ilar J."},{"issue":"6","key":"10.1016\/j.bbr.2023.114757_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbr.2023.114757_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2012.08.010","article-title":"Axonopathy in Huntington's disease","volume":"246","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib25","first-page":"145","article-title":"Importance of zebrafish as an efficient research model for the screening of novel therapeutics in neurological disorders","volume":"20","author":"Saluja","year":"2021","journal-title":"CNS Neurol. Disord. -Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord.)"},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7","article-title":"Generation and characterization of embryonic striatal conditionally immortalized ST14A cells","volume":"53","author":"Cattaneo","year":"1998","journal-title":"J. Neurosci. Res."},{"issue":"11","key":"10.1016\/j.bbr.2023.114757_bib27","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/00207450701769257","article-title":"In vitro characterization of embryionic ST14A-cells","volume":"118","author":"Hovakimyan","year":"2008","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bbr.2023.114757_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s13311-019-00782-9","article-title":"Cell-autonomous and non-cell-autonomous pathogenic mechanisms in Huntington\u2019s disease: insights from in vitro and in vivo models","volume":"16","author":"Creus-Muncunill","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"17","key":"10.1016\/j.bbr.2023.114757_bib29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.bbr.2023.114757_bib30","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/febs.12329","article-title":"In vitro and in vivo models of H untington's disease show alterations in the endocannabinoid system","volume":"280","author":"Bari","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbr.2023.114757_bib31","article-title":"Recent trends in detection of huntingtin and preclinical models of huntington\u2019s disease","volume":"2014","author":"Mantha","year":"2014","journal-title":"Int. Sch. Res. Not."},{"issue":"6","key":"10.1016\/j.bbr.2023.114757_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jbm.1072","article-title":"In vitro and in vivo biocompatibility testing of Ti\u20106Al\u20107Nb alloy with and without plasma\u2010sprayed hydroxyapatite coating","volume":"58","author":"Lavos\u2010Valereto","year":"2001","journal-title":"J. Biomed. Mater. Res.: Off. J. Soc. Biomater., Jpn. Soc. Biomater., Aust. Soc. Biomater. Korean Soc. Biomater."},{"key":"10.1016\/j.bbr.2023.114757_bib33","doi-asserted-by":"crossref","unstructured":"B\u00e9langer, M.C. and Y. Marois, Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low\u2010density polyethylene and polydimethylsiloxane: A review. Journal of Biomedical Materials Research: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials, 2001. 58(5): p. 467\u2013477.","DOI":"10.1002\/jbm.1043"},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib34","first-page":"291","article-title":"Experimental models of Huntington's disease","volume":"2","author":"Van Raamsdonk","year":"2005","journal-title":"Drug Discov. Today: Dis. Models"},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0975-7406.124301","article-title":"Use of rodents as models of human diseases","volume":"6","author":"Vandamme","year":"2014","journal-title":"J. Pharm. bioallied Sci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib36","first-page":"170","article-title":"Mouse models of human disease: an evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol. Med. Public Health"},{"issue":"5574","key":"10.1016\/j.bbr.2023.114757_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2023.114757_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0021-9258(18)56587-X","article-title":"Quinolinic acid metabolism. 1. Urinary excretion by the rat following tryptophan and 3-hydroxyanthranilic acid administration","volume":"181","author":"Henderson","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2023.114757_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1142\/9781860948022_0003","article-title":"Animal models of Huntington's disease","author":"Mitchell","year":"2006","journal-title":"Anim. Models Neuropsychiatr. Dis."},{"issue":"4868","key":"10.1016\/j.bbr.2023.114757_bib40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington's disease","volume":"241","author":"Young","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbr.2023.114757_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4939-7825-0_11","article-title":"Generating excitotoxic lesion models of Huntington\u2019s disease","author":"Lelos","year":"2018","journal-title":"Huntington\u2019s Dis."},{"issue":"36","key":"10.1016\/j.bbr.2023.114757_bib42","doi-asserted-by":"crossref","first-page":"19392","DOI":"10.1016\/S0021-9258(19)77645-5","article-title":"Neutral amino acid transport at the human blood-brain barrier","volume":"263","author":"Hargreaves","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bbr.2023.114757_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0014-4886(84)90239-5","article-title":"Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat","volume":"84","author":"Foster","year":"1984","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bbr.2023.114757_bib45","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/123.7.1442","article-title":"The influence of excitotoxic basal ganglia lesions on motor performance in the common marmoset","volume":"123","author":"Kendall","year":"2000","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib46","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1523\/JNEUROSCI.15-05-03775.1995","article-title":"Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models","volume":"15","author":"Portera-Cailliau","year":"1995","journal-title":"J. Neurosci."},{"issue":"5985","key":"10.1016\/j.bbr.2023.114757_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/311458a0","article-title":"Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum","volume":"311","author":"Isacson","year":"1984","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(94)00607-7","article-title":"GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease","volume":"66","author":"Nicholson","year":"1995","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.bbr.2023.114757_bib49","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/exnr.1993.1197","article-title":"Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome","volume":"124","author":"Roberts","year":"1993","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neuro.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.bbr.2023.114757_bib53","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00702-004-0201-4","article-title":"Huntington\u2019s disease: pathomechanism and therapeutic perspectives.","volume":"111","author":"G\u00e1rdi\u00e1n","year":"2004","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114757_bib55","article-title":"Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults","volume":"234","author":"Wiprich","year":"2020","journal-title":"Compar. Biochem. Physiol. Part C: Toxicol. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbr.2023.114757_bib56","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","article-title":"3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase","volume":"74","author":"Alston","year":"1977","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bbr.2023.114757_bib57","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1385-299X(96)00037-2","article-title":"Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model","volume":"1","author":"Borlongan","year":"1997","journal-title":"Brain Res. Protoc."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib59","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1531-8257(200005)15:3<524::AID-MDS1016>3.0.CO;2-F","article-title":"Delayed onset of progressive dystonia following subacute 3\u2013nitropropionic acid treatment in Cebus apella monkeys","volume":"15","author":"Palfi","year":"2000","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"issue":"10","key":"10.1016\/j.bbr.2023.114757_bib60","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2023.114757_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.654238","article-title":"Impulse control disorders in Parkinson\u2019s disease: from bench to bedside","volume":"15","author":"Augustine","year":"2021","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/hmg\/5.2.177","article-title":"Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript","volume":"5","author":"Goldberg","year":"1996","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.bbr.2023.114757_bib64","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/6.10.1633","article-title":"Transgenic models of Huntington's disease","volume":"6","author":"Bates","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2023.114757_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of Huntington\u2019s disease","author":"Farshim","year":"2018","journal-title":"Huntington\u2019s Dis."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.47","article-title":"Overview of Huntington's disease models: neuropathological, molecular, and behavioral differences","volume":"83","author":"Rangel\u2010Barajas","year":"2018","journal-title":"Curr. Protoc. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.bbr.2023.114757_bib68","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","article-title":"Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease","volume":"15","author":"Nguyen","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2023.114757_bib69","first-page":"101","article-title":"Mouse models of Huntington\u2019s disease","author":"Brooks","year":"2015","journal-title":"Behav. Neurobiol. Huntingt.'s. Dis. Park.'s. Dis."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib70","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.bbr.2023.114757_bib71","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2023.114757_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00593-7","article-title":"A clinical study of patients with genetically confirmed Huntington's disease from India","volume":"190","author":"Murgod","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock\u2010in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"issue":"12","key":"10.1016\/j.bbr.2023.114757_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.bbr.2023.114757_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bbr.2023.114757_bib76","series-title":"Cold Spring Harbor symposia on quantitative biology","article-title":"Targeted inactivation of the mouse Huntington's disease gene homolog Hdh","author":"MacDonald","year":"1996"},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib77","first-page":"615","article-title":"Homozygote for Huntington disease","volume":"45","author":"Myers","year":"1989","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/j.bbr.2023.114757_bib79","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"10.1016\/j.bbr.2023.114757_bib80","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bbr.2023.114757_bib81","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I","article-title":"Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits","volume":"42","author":"Lu","year":"1998","journal-title":"J. Biomed. Mater. Res.: Off. J. Soc. Biomater., Jpn. Soc. Biomater., Aust. Soc. Biomater."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib83","first-page":"155","article-title":"In vitro and in vivo tests for the biological evaluation of candidate orthopedic materials: Benefits and limits","volume":"1","author":"Fini","year":"2003","journal-title":"J. Appl. Biomater. Biomech."},{"key":"10.1016\/j.bbr.2023.114757_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104679","article-title":"Modeling neurodegenerative disorders in zebrafish","volume":"138","author":"Bashirzade","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2023.114757_bib85","first-page":"1","article-title":"Zebrafish an experimental model of Huntington\u2019s disease: Molecular aspects, therapeutic targets and current challenges","author":"Kumar","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.bbr.2023.114757_bib86","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuro.2011.05.010","article-title":"Chronic ethanol treatment alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in zebrafish brain","volume":"32","author":"Rico","year":"2011","journal-title":"Neurotoxicology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2023.114757_bib87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-1119(98)00342-4","article-title":"Characterization of the Huntington's disease (HD) gene homolog in the zebrafish Danio rerio","volume":"217","author":"Karlovich","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.bbr.2023.114757_bib88","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neubiorev.2014.06.013","article-title":"Huntington disease: can a zebrafish trail leave more than a ripple?","volume":"45","author":"Das","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2023.114757_bib89","first-page":"65","article-title":"The biological function of the Huntingtin protein and its relevance to Huntington\u2019s Disease pathology","volume":"5","author":"Schulte","year":"2011","journal-title":"Curr. Trends Neurol."},{"issue":"23","key":"10.1016\/j.bbr.2023.114757_bib90","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2023.114757_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbr.2023.114757_bib92","first-page":"376","article-title":"Zebrafish as a model organism for human neurodegenerative diseases","author":"Chia","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib93","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.6039-08.2009","article-title":"Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish","volume":"29","author":"Diekmann","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3490","article-title":"Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction","volume":"4","author":"Anastasia","year":"2013","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbr.2023.114757_bib95","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/emboj\/17.9.2534","article-title":"Early evolutionary origin of the neurotrophin receptor family","volume":"17","author":"van Kesteren","year":"1998","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib96","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0959-4388(99)00011-2","article-title":"Evolution of the vertebrate neurotrophin and Trk receptor gene families","volume":"9","author":"Hallb\u00f6\u00f6k","year":"1999","journal-title":"Curr. Opin. Neurobiol."},{"issue":"10","key":"10.1016\/j.bbr.2023.114757_bib97","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3390\/ijms19103155","article-title":"BDNF, brain, and regeneration: insights from zebrafish","volume":"19","author":"Lucini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbr.2023.114757_bib98","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/gt.2012.84","article-title":"In vivo delivery of DN: REST improves transcriptional changes of REST-regulated genes in HD mice","volume":"20","author":"Conforti","year":"2013","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib99","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.14723","article-title":"Alterations in synaptic function and plasticity in Huntington disease","volume":"150","author":"Smith\u2010Dijak","year":"2019","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bbr.2023.114757_bib100","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1080\/1028415X.2021.1956254","article-title":"Neuroprotective effects of rutin on ASH neurons in Caenorhabditis elegans model of Huntington\u2019s disease","volume":"25","author":"Cordeiro","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173644","article-title":"A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles","volume":"12","author":"Lee","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1073\/pnas.96.1.179","article-title":"Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron","volume":"96","author":"Faber","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ng1095-115","article-title":"HEAT repeats in the Huntington's disease protein","volume":"11","author":"Andrade","year":"1995","journal-title":"Nat. Genet."},{"issue":"5461","key":"10.1016\/j.bbr.2023.114757_bib104","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1126\/science.287.5461.2204","article-title":"Comparative genomics of the eukaryotes","volume":"287","author":"Rubin","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbr.2023.114757_bib105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1101\/gr.169101","article-title":"A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster","volume":"11","author":"Reiter","year":"2001","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(02)00707-9","article-title":"Spatial representation of the glomerular map in the Drosophila protocerebrum","volume":"109","author":"Wong","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0092-8674(02)00700-6","article-title":"Representation of the glomerular olfactory map in the Drosophila brain","volume":"109","author":"Marin","year":"2002","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0960-9822(02)00656-5","article-title":"The Drosophila standard brain","volume":"12","author":"Rein","year":"2002","journal-title":"Curr. Biol."},{"issue":"6857","key":"10.1016\/j.bbr.2023.114757_bib109","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbr.2023.114757_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007275","article-title":"RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation","volume":"4","author":"Doumanis","year":"2009","journal-title":"PloS One"},{"issue":"Suppl_2","key":"10.1016\/j.bbr.2023.114757_bib111","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1093\/hmg\/ddg271","article-title":"Fly models of Huntington's disease","volume":"12","author":"Marsh","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/hmg\/9.1.13","article-title":"Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila","volume":"9","author":"Marsh","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2023.114757_bib113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneumeth.2015.07.026","article-title":"Using Drosophila models of Huntington's disease as a translatable tool","volume":"265","author":"Lewis","year":"2016","journal-title":"J. Neurosci. Methods"},{"issue":"20","key":"10.1016\/j.bbr.2023.114757_bib114","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bbr.2023.114757_bib115","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5512","key":"10.1016\/j.bbr.2023.114757_bib116","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"issue":"5459","key":"10.1016\/j.bbr.2023.114757_bib117","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.287.5459.1837","article-title":"Genetic suppression of polyglutamine toxicity in Drosophila","volume":"287","author":"Kazemi-Esfarjani","year":"2000","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib118","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nchembio.1790","article-title":"siRNA screen identifies QPCT as a druggable target for Huntington's disease","volume":"11","author":"Jimenez-Sanchez","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bbr.2023.114757_bib119","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","article-title":"A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease","volume":"173","author":"Yan","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbr.2023.114757_bib120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib121","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib122","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer's disease in mice","volume":"66","author":"Ashe","year":"2010","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib123","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2009.10.020","article-title":"Searching for new animal models of Alzheimer\u2032 s disease","volume":"626","author":"Epis","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-animal-031412-103715","article-title":"Genetically engineered pig models for human diseases","volume":"1","author":"Prather","year":"2013","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.4654","article-title":"Genetically modified pig models for neurodegenerative disorders","volume":"238","author":"Holm","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbr.2023.114757_bib127","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00018-014-1744-7","article-title":"Generation of CRISPR\/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer","volume":"72","author":"Zhou","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib128","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/jmcb\/mjw008","article-title":"Genetically humanized pigs exclusively expressing human insulin are generated through custom endonuclease-mediated seamless engineering","volume":"8","author":"Yang","year":"2016","journal-title":"J. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib129","first-page":"184","article-title":"Generation of Hoxc13 knockout pigs recapitulates human ectodermal dysplasia\u20139","volume":"26","author":"Han","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JHD-130001","article-title":"A transgenic minipig model of Huntington's disease","volume":"2","author":"Baxa","year":"2013","journal-title":"J. Huntingt.'s Dis."},{"issue":"3\u20134","key":"10.1016\/j.bbr.2023.114757_bib131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000443665","article-title":"Mutated huntingtin causes testicular pathology in transgenic minipig boars","volume":"16","author":"Macakova","year":"2016","journal-title":"Neurodegener. Dis."},{"issue":"9","key":"10.1016\/j.bbr.2023.114757_bib132","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","article-title":"AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington\u2019s disease minipig model","volume":"26","author":"Evers","year":"2018","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.bbr.2023.114757_bib133","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0315-18.2018","article-title":"What, if anything, is rodent prefrontal cortex?","volume":"5","author":"Laubach","year":"2018","journal-title":"eneuro"},{"issue":"3","key":"10.1016\/j.bbr.2023.114757_bib134","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JHD-200425","article-title":"Large animal models of Huntington\u2019s disease: what we have learned and where we need to go next","volume":"9","author":"Howland","year":"2020","journal-title":"J. Huntingt.'s. Dis."},{"issue":"8","key":"10.1016\/j.bbr.2023.114757_bib135","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63559-7","article-title":"Intra-striatal AAV2. retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development","volume":"10","author":"Weiss","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2023.114757_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104951","article-title":"Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates","volume":"141","author":"Maxan","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"7197","key":"10.1016\/j.bbr.2023.114757_bib138","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington\u2019s disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbr.2023.114757_bib139","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ymthe.2018.07.008","article-title":"Extensive transduction and enhanced spread of a modified AAV2 capsid in the non-human primate CNS","volume":"26","author":"Naidoo","year":"2018","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13041-020-00679-1","article-title":"AAV9-Retro mediates efficient transduction with axon terminal absorption and blood\u2013brain barrier transportation","volume":"13","author":"Lin","year":"2020","journal-title":"Mol. Brain"},{"issue":"2","key":"10.1016\/j.bbr.2023.114757_bib141","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","article-title":"A designer AAV variant permits efficient retrograde access to projection neurons","volume":"92","author":"Tervo","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbr.2023.114757_bib142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0963180119000732","article-title":"A Belmont report for animals?","volume":"29","author":"Ferdowsian","year":"2020","journal-title":"Camb. Q. Healthc. Ethics"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823004758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823004758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:43:34Z","timestamp":1759067014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823004758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":142,"alternative-id":["S0166432823004758"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114757","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling Huntington\u2019s disease: An insight on in-vitro and in-vivo models","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114757"}}